Back to User profile » Dr Nasser Alorfi
Papers published by Dr Nasser Alorfi:
Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:575375
Published Date: 14 May 2026
GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies
Alourfi NM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2026, 19:584052
Published Date: 3 February 2026
Pharmacological Interventions in the Management of Sports Injuries: A Review of Clinical Use, Dosage Forms, and Anti-Doping Considerations
Alorfi NM
Drug Design, Development and Therapy 2026, 20:587793
Published Date: 2 February 2026
Pharmacological Management of Post-Traumatic Stress Disorder; A Qualitative Analysis of ClinicalTrials.gov
Alorfi NM
Drug Design, Development and Therapy 2025, 19:9697-9708
Published Date: 29 October 2025
Hospital Pharmacists’ Perspectives on Communicating with Hearing-Impaired Patients in Pharmacy Settings: A Qualitative Study
Alorfi NM, Alshehri FS, Ashour AM, Wali SM, Almuzaini OK, Ainousah BE, Aldurdunji MM, Alhasani RH, Mohammad BA, Alamri MA, Alharthi MS, Yousuf GK, Alkhanani MF, Aldekhail NM
International Journal of General Medicine 2025, 18:5989-5994
Published Date: 1 October 2025
Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov
Ashour AM, Harbi MH, Alshehri FS, Wali SM, Aldurdunji MM, Alorfi NM
Journal of Multidisciplinary Healthcare 2025, 18:5865-5874
Published Date: 16 September 2025
Investigating Therapeutic Targets for Alcohol Use Disorder: Pharmacological View of ClinicalTrials.gov Data
Alorfi NM
International Journal of General Medicine 2025, 18:3701-3712
Published Date: 4 July 2025
Public Awareness About Frailty Prevention and Possible Association Between Frailty and Disability: A Cross-Sectional Study in Saudi Arabia
Ashour AM, Harbi MH, Alorfi NM, Alshehri FS, Wali SM, Aldurdunji MM
Risk Management and Healthcare Policy 2025, 18:1713-1720
Published Date: 23 May 2025
Public Awareness and Perceptions of Congenital Disabilities in Saudi Arabia: A Cross-Sectional Study
Alshehri FS, Ashour AM, Alorfi NM
Risk Management and Healthcare Policy 2025, 18:1069-1083
Published Date: 28 March 2025
Therapeutics for Sarcopenia and Functional Disabilities in Older Adults: A Review of Phase 4 Clinical Trials
Alorfi NM, Alshehri FS, Ashour AM
Drug Design, Development and Therapy 2025, 19:2307-2314
Published Date: 27 March 2025
Current Perspectives, Practices, and Barriers Faced by Community Pharmacists Regarding Pharmaceutical Care Services for Diabetes Mellitus in the United Arab Emirates
Jairoun AA, Al-Hemyari SS, Shahwan M, Jairoun SA, Alorfi NM, Zyoud SH, Suliman AA, Shahwan MK, Alnuaimi G, Shahwan M, Al-Qirim T, El-Dahiyat F
Journal of Multidisciplinary Healthcare 2024, 17:2563-2576
Published Date: 23 May 2024
Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis
Hegazi OE, Alalalmeh SO, Shahwan M, Jairoun AA, Alourfi MM, Bokhari GA, Alkhattabi A, Alsharif S, Aljehani MA, Alsabban AM, Almtrafi M, Zakri YA, AlMahmoud A, Alghamdi KM, Ashour AM, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2024, 17:545-561
Published Date: 2 February 2024
Saudi Adults’ Understanding and Views of Weight Management Practices and Obesity
Alshehri FS, Alorfi NM
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3513-3531
Published Date: 6 November 2023
The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry
Alorfi NM, Ashour AM
Diabetes, Metabolic Syndrome and Obesity 2023, 16:3115-3121
Published Date: 6 October 2023
Comprehensive Review of Ustekinumab Utilization in Inflammatory Bowel Diseases: Insights from the ClinicalTrials.gov Registry
Alorfi NM, Alourfi MM, Bokhari GA, Alkhattabi A, Ibrahim NA, Alsabban AM, Almatrafi MJ, Zakri YA, Almahmoud AJ, Al-ghamdi KMA, Alsharif SN
International Journal of General Medicine 2023, 16:4283-4294
Published Date: 20 September 2023
A Study to Assess Prescription Transfer and Medicines Collection Through a New Electronic Prescription Service: A Cross-Sectional Survey
Tobaiqy M, Ainousah BE, Alorfi NM, Alghamdi A, Alqutub ST
International Journal of General Medicine 2023, 16:3689-3699
Published Date: 22 August 2023
Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov
Alorfi NM, Alshehri FS
Journal of Multidisciplinary Healthcare 2023, 16:2179-2187
Published Date: 31 July 2023
Pharmacological Methods of Pain Management: Narrative Review of Medication Used
Alorfi NM
International Journal of General Medicine 2023, 16:3247-3256
Published Date: 31 July 2023
Assessment of the Community Pharmacists’ Knowledge and Attitudes Toward Pain and Pain Management in Saudi Arabia
Alorfi NM, Ashour AM, Algarni AS, Alsolami FA, Alansari AM, Tobaiqy M
International Journal of General Medicine 2022, 15:8527-8537
Published Date: 7 December 2022
Public Awareness of Alzheimer’s Disease: A Cross-Sectional Study from Saudi Arabia
Alorfi NM
International Journal of General Medicine 2022, 15:7535-7546
Published Date: 28 September 2022
Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
Alorfi NM, Alourfi MM
Biologics: Targets and Therapy 2022, 16:119-127
Published Date: 5 August 2022
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Alorfi NM, Algarni AS
Clinical Pharmacology: Advances and Applications 2022, 14:61-67
Published Date: 3 August 2022
Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia
Alorfi N, Ashour A
Clinical Pharmacology: Advances and Applications 2022, 14:27-35
Published Date: 5 April 2022